May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Venezuela
Clicks: 2
ID: 323244
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #47 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract This article presents the findings of the May Measurement Month (MMM) 2023 campaign in Venezuela, conducted to raise awareness about elevated blood pressure (BP). Adults (≥18 years) were recruited through convenience sampling across 98 sites in eight Venezuelan regions, mainly in branches of FARMATODO (82.8%). Three seated BP measurements were obtained from each participant, and a standardized questionnaire collected data on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg and/or a diastolic BP ≥90mmHg, or current use of BP-lowering medication. Controlled BP was defined as being on antihypertensive treatment with a BP <140/90mmHg. Of the 56,910 participants screened (mean age: 58.3 years, 57.1% female), 35,384 (62.2%) participants had hypertension, of whom 29,551 (83.5%) were aware of their condition and 29,134 (82.3%) were receiving antihypertensive medication. Among those treated, 17,746 (60.9%) had controlled BP, and among all participants with hypertension, 50.2% had controlled BP. Half (51.4%) of treated individuals were taking one class of drug. Other cardiovascular risk factors were prevalent: 9.5% of participants reported diabetes (76.4% of whom were also hypertensive), 56.8% were overweight or obese (Body Mass Index ≥25 kg/m2), and 52% reported physical activity less than guideline recommendations. Abdominal obesity was observed in 53.1% of females and 24.3% of males. In conclusion, the MMM23 campaign in Venezuela identified a substantial number of participants with untreated or inadequately controlled hypertension and other cardiovascular risk factors, highlighting the urgent need for enhanced strategies for BP screening, management, and overall cardiovascular health promotion.
| Reference Key |
openalex_W7172287722
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | María José Armas-Hernández, Mónica L Gúzman-Franolic, Thomas Beaney, Gabriele Kerr, Yuly Rawik-Dagher, Neil R Poulter, Beatriz Sosa-Canache, Amanda Duin-Balza, M C Armas-Padilla, José Andrés Octavio-Seijas, Igor Morr, Jesús López-Rivera, Rafael Hernández-Hernandez |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag112
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.